2025 SABCS Highlights: Advances in ctDNA for Breast Cancer

Harold Burstein, MD, PhD, and Ilana Schlam, MD, MPH, discuss important advances in ctDNA and minimal residual disease (MRD) for breast cancer in the neoadjuvant, adjuvant, and advance settings. This research was presented at the 2025 San Antonio Breast Cancer Symposium.